In Vivo Emergence of Resistance to Novel Cephalosporin-{beta}-Lactamase Inhibitor Combinations through the Duplication of Amino Acid D149 from OXA-2 {beta}-Lactamase (OXA-539) in Sequence Type 235 Pseudomonas aeruginosa [Mechanisms of Resistance]
Antimicrobial Agents, and Chemotherapry,
ABSTRACT Resistance development to novel cephalosporin–β-lactamase inhibitor combinations during ceftazidime treatment of a…